1.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VPA-CdA, NCT01295593
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Approved-not yet active Age: 18 to 90 Sponsor: Other Protocol IDs: Allo-Relapse-2011, NCT01369368
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: Version1.1, NCT01622439
|
|
4.
|
Phase: Phase II Type: Treatment Status: Approved-not yet active Age: 18 to 75 Sponsor: Other Protocol IDs: SOR513511CTIL, NCT01333631
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: P081225, NCT01342692
|
|
6.
|
Phase: Phase II Type: Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: SMD-TXAGO, NCT01356875
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: Under 60 Sponsor: Other Protocol IDs: 327/11, NCT01695122
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MCC-14816, HM14816, NCT01817751
|
|
9.
|
Phase: Phase I Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2012-0061, NCT01552434
|
|
10.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Over 21 Sponsor: Other Protocol IDs: 256549, NCT01738815
|